Deal Asset Classification
A categorical description of the main type of asset being acquired, partnered, or
otherwise transacted. Multiple assets within the same type are grouped together.
For example, a deal for two compounds will have a single asset type of Pharmaceutical
Products and the corresponding Number of Products field will indicate multiple products
within that asset type. A deal involving more than one distinct asset type, such
as a partnership for a technology platform with an option to acquire the company,
will be a multiple asset type deal with each asset type containing its own corresponding
categories and financial terms. BCIQ Deal Analyst search result tables and Deal
Profiles will allow the differentiation of single and multiple asset type deals
(see also Number or Asset Types and Number of Products).
M&A deals are located in the separate M&A section accessible from the top of the section header.
An entire company that may be purchased in a full or majority acquisition that may
potentially encompass the entire legal entity. This does not include business units,
divisions, or facilities as those may be transacted in an asset purchase rather
than a company merger or acquisition (see Business Units, Divisions or Facilities).
Pharmaceutical products include marketed human therapeutics and identified compounds
in preclinical or later stages.
Drug Target Technology
Technology used to discover or manipulate targets. This does not include technologies
to discover compounds against targets (see Discovery Technology).
Technologies used to discover compounds against targets and biomarkers for diseases.
This includes therapeutic modality platforms (biologics, antibodies, RNA, proteins,
macrocycles), genomics, screening technologies, etc.
Delivery and Formulation Technology
Technologies used to alter the delivery or formulation of drugs. This includes sustained
release, extended release, abuse deterrents, vector technology, etc.
Technologies used in the manufacturing of pharmaceutical products. This includes
active pharmaceutical ingredients (API), cell lines, scale-up, fill and finish,
Technologies that cannot be classified under any other technology platform category
Medical Devices and Diagnostics
Drug Delivery Device
A device used to deliver a drug. This includes inhalers, stents (incl. drug eluting/coated
stents), pumps, injection devices, pre-filled syringes, patches, etc.
Medical devices that provide therapeutic treatment. This includes cryotherapy, thermotherapy,
electromagnetic, laser, photodynamic therapy, sonication, ultrasound, and other
therapeutic devices (see Drug Delivery Device for drug/device combinations).
Biomarker / Companion Diagnostic
Biomarkers are specific genes or genetic markers that may indicate disease. This
includes both the biomarker and IP relating to the biomarker that have already been
discovered prior to deal signing. Companion diagnostics are developed in conjunction
with a specific pharmaceutical product (see Discovery Technology for biomarker and
companion diagnostic discovery technology).
Diagnostics that cannot be classified under any other diagnostic category above
Device that cannot be classified under any other medical device category above
Business Units, Divisions or Facilities
Business Unit or Division
A separate operating business or division of a larger company or holding company.
This also includes subsidiaries of larger companies.
Manufacturing plants, factories, labs, research centers, and office buildings
Research performed by a contract research organization (CRO) without any rights
to the resulting product or technology
Manufacturing performed by a contract manufacturing organization (CMO) without any
rights to the manufactured product
Sales and marketing services performed by a contract sales organization (CSO) without
any rights to the marketed product
Services that cannot be classified under any other contract services category above
Data or Freedom to Operate
Data includes intellectual property (IP), patents, and clinical data. Freedom to
operate is freedom from being legally prosecuted for the use of the particular asset.
Grants provided by non-profits and foundations. This does not include grants from
the National Institutes of Health (NIH) or SBIR grants.